Fosun International LTD Incyte Corp Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$72.82 - $86.52 $8.69 Million - $10.3 Million	-119,310 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$73.52 - $88.7 $2.54 Million - $3.06 Million	34,500 Added 40.68%	119,310 $10.1 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $521,192 - $722,994	8,200 Added 10.7%	84,810 $7.27 Million
Q4 2018 Jan 31, 2019	BUY	$58.5 - $69.94 $1.58 Million - $1.89 Million	27,000 Added 54.42%	76,610 $4.78 Million
Q3 2018 Nov 09, 2018	BUY	$61.75 - $74.23 $3.06 Million - $3.68 Million	49,610 New	49,610 $3.43 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.